Massive astrocyte destruction in neuromyelitis optica despite natalizumab therapy

Multiple Sclerosis Journal

Volumn 18, Issue 1, 2012, Pages 108-112

  Barnett, M H ^a,b   Prineas, J W ^a,b   Buckland, M E ^a,b   Parratt, Jde ^b   Pollard, J D ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

demyelination; immunology; relapsing remitting; Tysabri

Indexed keywords

AQUAPORIN 4; AUTOANTIBODY; BETA1A INTERFERON; BIOLOGICAL MARKER; FLUORODEOXYGLUCOSE F 18; GADOLINIUM PENTETATE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE; NATALIZUMAB; PREDNISOLONE; RITUXIMAB;

ARTICLE; ASTROCYTE; DEMYELINATING DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG MEGADOSE; EVOKED VISUAL RESPONSE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVE CELL NECROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; RELAPSE; REMISSION; TREATMENT OUTCOME;

EID: 84855959569     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511421185     Document Type: Article

References (15)

1. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004 ; 364: 2106-2112 (Pubitemid 39626806)
2. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol. 2006 ; 63: 964-968 (Pubitemid 44036298)
3. Parratt JD, Prineas JW. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes. Mult Scler. 2010 ; 16: 1156-1172
4. Takano R, Misu T, Takahashi T, Sato S, Fujihara K, Itoyama Y. Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study. Neurology. 2010 ; 75: 208-216
5. Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol. 2009 ; 66: 630-643
6. Shimizu J, Hatanaka Y, Hasegawa M, Iwata A, Sugimoto I, Date H, et al. IFN{beta}-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology. 2010 ; 77: 195-196
7. Weinshenker BG, Wingerchuk DM, Vukusic S, Linbo L, Pittock SJ, Lucchinetti CF, et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol. 2006 ; 59: 566-569 (Pubitemid 43358081)
8. Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002 ; 125: 1450-1461 (Pubitemid 34755161)
9. Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain. 2007 ; 130: 1224-1234 (Pubitemid 47355951)
10. Kivisakk P, Healy BC, Viglietta V, Quintana FJ, Hootstein MA, Weiner HL, et al. Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells. Neurology. 2009 ; 72: 1922-1930
11. Putzki N, Baranwal MK, Tettenborn B, Limmroth V, Kreuzfelder E. Effects of natalizumab on circulating B cells, T regulatory cells and natural killer cells. Eur Neurol. 2010 ; 63: 311-317
12. Krumbholz M, Meinl I, Kumpfel T, Hohlfeld R, Meinl E. Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology. 2008 ; 71: 1350-1354
13. Ishizu T, Osoegawa M, Mei FJ, Kikuchi H, Tanaka M, Takakura Y, et al. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain. 2005 ; 128: 988-1002 (Pubitemid 40675455)
14. Barnett MH, Parratt JD, Cho ES, Prineas JW. Immunoglobulins and complement in postmortem multiple sclerosis tissue. Ann Neurol. 2009 ; 65: 32-46
15. Stenner MP, Waschbisch A, Buck D, Doerck S, Einsele H, Toyka KV, et al. Effects of natalizumab treatment on Foxp3+ T regulatory cells. PLoS One. 2008 ; 3: e3319